ORANGEKLOUD TECHNOLOGY INC (ORKT)

KYG6781F1019 - Common Stock

2.45  +0.1 (+4.26%)

After market: 2.42 -0.03 (-1.22%)

Fundamental Rating

1

Taking everything into account, ORKT scores 1 out of 10 in our fundamental rating. ORKT was compared to 83 industry peers in the IT Services industry. The financial health of ORKT is average, but there are quite some concerns on its profitability. ORKT has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year ORKT has reported negative net income.
ORKT had a negative operating cash flow in the past year.

1.2 Ratios

ORKT's Return On Assets of -52.43% is on the low side compared to the rest of the industry. ORKT is outperformed by 92.59% of its industry peers.
With a Return On Equity value of -105.63%, ORKT is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -52.43%
ROE -105.63%
ROIC N/A
ROA(3y)0.02%
ROA(5y)N/A
ROE(3y)0.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 44.64%, ORKT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
ORKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

ORKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ORKT has about the same amount of shares outstanding.
The debt/assets ratio for ORKT is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 22.44 indicates that ORKT is not in any danger for bankruptcy at the moment.
ORKT's Altman-Z score of 22.44 is amongst the best of the industry. ORKT outperforms 97.53% of its industry peers.
ORKT has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
ORKT has a better Debt to Equity ratio (0.24) than 60.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 22.44
ROIC/WACCN/A
WACC11.91%

2.3 Liquidity

ORKT has a Current Ratio of 1.42. This is a normal value and indicates that ORKT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.42, ORKT is in line with its industry, outperforming 43.21% of the companies in the same industry.
ORKT has a Quick Ratio of 1.42. This is a normal value and indicates that ORKT is financially healthy and should not expect problems in meeting its short term obligations.
ORKT has a Quick ratio of 1.42. This is comparable to the rest of the industry: ORKT outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42

0

3. Growth

3.1 Past

The earnings per share for ORKT have decreased strongly by -166.67% in the last year.
Looking at the last year, ORKT shows a very negative growth in Revenue. The Revenue has decreased by -14.86% in the last year.
EPS 1Y (TTM)-166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.93%
Revenue 1Y (TTM)-14.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

ORKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ORKT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORANGEKLOUD TECHNOLOGY INC

NASDAQ:ORKT (12/24/2024, 7:29:58 PM)

After market: 2.42 -0.03 (-1.22%)

2.45

+0.1 (+4.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.33%
Ins Owner ChangeN/A
Market Cap56.74M
AnalystsN/A
Price TargetN/A
Short Float %2.62%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.59
P/FCF N/A
P/OCF N/A
P/B 36.79
P/tB 159.78
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.29
BVpS0.07
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.43%
ROE -105.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.64%
FCFM N/A
ROA(3y)0.02%
ROA(5y)N/A
ROE(3y)0.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.13
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.54%
Cap/Sales 0.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 22.44
F-Score2
WACC11.91%
ROIC/WACCN/A
Cap/Depr(3y)191.94%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-174.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-232.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.17%
OCF growth 3YN/A
OCF growth 5YN/A